Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts. (3rd April 2021)

• Record Type: Journal Article
• Authors: Ring, J.; Worm, M.; Wollenberg, A.; Thyssen, J.P.; Jakob, T.; Klimek, L.; Bangert, C.; Barbarot, S.; Bieber, T.; de Bruin‐Weller, M.S.; Chernyshov, P.V.; Christen‐Zaech, S.; Cork, M.; Darsow, U.; Flohr, C.; Fölster‐Holst, R.; Gelmetti, C.; Gieler, U.; Gutermuth, J.; Heratizadeh, A.; Hijnen, D.J.; von Kobyletzki, L.B.; Kunz, B.; Paul, C.; De Raeve, L.; Seneschal, J.; Simon, D.; Spuls, P.I.; Stalder, J.F.; Svensson, A.; Szalai, Z.; Taieb, A.; Torrelo, A.; Trzeciak, M.; Vestergaard, C.; Werfel, T.; Weidinger, S.; Deleuran, M.;
• Is Part Of: Journal of the European Academy of Dermatology and Venereology. Volume 35:Number 6(2021)
• Page Start: e362
• Page End: e365
• Publication Date: 2021-04-03
• Subjects: Dermatology -- Periodicals; Sexually transmitted diseases -- Periodicals; 616.5
• DOI: 10.1111/jdv.17237
• Languages: English
• ISSNs: 0926-9959